Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
J Int Med Res ; 49(3): 300060520981362, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33730887

ABSTRACT

Lipoblastomas and liposarcomas are rare causes of soft tissue masses in paediatric patients. In this retrospective clinical case series we identified 11 patients from our paediatric database (10 with a lipoblastoma and one with a liposarcoma) who had attended our hospital between 1998 and 2019. The median age of patients with lipoblastoma was 29 months. All lipoblastoma cases were managed with surgical excision and histological examination. The 18-year old patient with liposarcoma presented with a metastatic and unresectable tumour that was unresponsive to chemotherapy and radiation. Our experience demonstrates the importance of differentiating the type of soft tissue mass in children.


Subject(s)
Lipoblastoma , Liposarcoma , Adolescent , Child , Child, Preschool , Humans , Lipoblastoma/diagnostic imaging , Lipoblastoma/surgery , Liposarcoma/diagnostic imaging , Liposarcoma/surgery , Retrospective Studies
2.
Mod Pathol ; 33(Suppl 1): 66-82, 2020 01.
Article in English | MEDLINE | ID: mdl-31685962

ABSTRACT

Cutaneous soft tissue tumors with epithelioid features present a diagnostic challenge given that many entities in this category are rare, and they show morphologic overlap with significantly more common cutaneous epithelial and melanocytic neoplasms. The challenge is compounded by overlapping expression of epithelial or melanocytic markers in some of these entities. A broad spectrum of primary cutaneous epithelioid soft tissue tumors exists, including benign and malignant counterparts of tumors with various differentiation including melanocytic, peripheral nerve sheath, angiomatous, fibrohistiocytic, and myoid or myoepithelial, in addition to translocation-associated tumors lacking a derivative tissue type. Given this spectrum, an initial targeted immunohistochemical panel for epithelioid dermal and subcutaneous neoplasms is recommended, covering a broad spectrum of differentiation. In diagnostically challenging cases, select molecular studies can be employed to make critical distinctions between entities sharing morphologic and immunohistochemical properties. Due to sometimes marked differences in prognosis and treatment, knowledge and familiarity with epithelioid soft tissue tumors is key for any surgical pathologist who evaluates skin and subcutaneous biopsies and excision specimens. This concise review provides brief descriptions, key diagnostic features, and important modern ancillary studies for the diagnosis of non-epithelial, non-melanocytic cutaneous tumors that can exhibit a prominent degree of epithelioid morphology.


Subject(s)
Cell Differentiation , Epithelioid Cells/pathology , Histiocytoma, Malignant Fibrous/pathology , Nerve Sheath Neoplasms/pathology , Skin Neoplasms/pathology , Soft Tissue Neoplasms/pathology , Biomarkers, Tumor/analysis , Biopsy , Diagnosis, Differential , Epithelioid Cells/chemistry , Histiocytoma, Malignant Fibrous/chemistry , Histiocytoma, Malignant Fibrous/classification , Humans , Nerve Sheath Neoplasms/chemistry , Nerve Sheath Neoplasms/classification , Predictive Value of Tests , Skin Neoplasms/chemistry , Skin Neoplasms/classification , Soft Tissue Neoplasms/chemistry , Soft Tissue Neoplasms/classification , Terminology as Topic
3.
Arch Pathol Lab Med ; 143(12): 1504-1512, 2019 12.
Article in English | MEDLINE | ID: mdl-31765250

ABSTRACT

CONTEXT.­: Ossifying fibromyxoid tumor (OFMT) is a rare, slow-growing mesenchymal neoplasm of uncertain histogenesis with intermediate malignant potential. OBJECTIVE.­: To highlight the most important diagnostic features, including morphologic, immunohistochemical, and molecular findings; to provide comparisons to other entities in the differential diagnosis; and to provide a summary of the clinical features and outcomes in cases reported to date. DATA SOURCES.­: The data sources include recently published literature encompassing OFMT and tumors in the histologic differential diagnosis, and cases from institutional files. CONCLUSIONS.­: Ossifying fibromyxoid tumor is important to recognize because of its low-grade morphology but potential for recurrence and metastasis. Recent molecular analysis has expanded the morphologic spectrum of OFMT, with additional cases discovered that are enriched for aggressive behavior. The diagnosis can often be rendered through a combination of morphology and coexpression of S100 protein and desmin, although only a minority of cases described contain all of these primary features. In cases that do not have all of these features, a high index of suspicion guided by morphology and exclusion of other tumors in the histologic differential diagnosis can lead to the correct diagnosis. Growing access to molecular genetic testing will become increasingly important for correct diagnosis of tumors at the ends of the morphologic spectrum.


Subject(s)
Fibroma, Ossifying/diagnosis , Fibroma, Ossifying/pathology , Soft Tissue Neoplasms/diagnosis , Soft Tissue Neoplasms/pathology , Diagnosis, Differential , Humans
4.
Arch Pathol Lab Med ; 143(12): 1497-1503, 2019 12.
Article in English | MEDLINE | ID: mdl-31765251

ABSTRACT

CONTEXT.­: Cellular spindled histiocytic pseudotumor (CSHPT) is an exuberant, dense histiocytic proliferation seen in the setting of mammary fat necrosis. CSHPT has a broad histologic differential diagnosis, including benign, malignant, and inflammatory etiologies. OBJECTIVES.­: To highlight the most important histologic and immunohistochemical findings of CSHPT and provide comparisons to entities within the broad differential diagnosis. DATA SOURCES.­: Recently published literature regarding CSHPT and other diagnostic considerations. CONCLUSIONS.­: CSHPT is a benign histiocytic proliferation with a broad differential diagnosis, for which comprehensive ancillary studies may be required to exclude malignant and infectious entities.


Subject(s)
Breast Diseases/diagnosis , Breast Diseases/pathology , Breast Neoplasms/diagnosis , Fat Necrosis/pathology , Histiocytes/pathology , Breast Neoplasms/pathology , Diagnosis, Differential , Female , Humans
5.
Surg Pathol Clin ; 12(1): 191-215, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30709443

ABSTRACT

Round cell sarcomas morphologically similar to Ewing sarcoma, but lacking the classic immunohistochemical features, EWSR-ETS family fusions, and other signs of differentiation, are classified as Ewing-like sarcomas. Recent molecular advances led to the discovery and characterization of two recurrent oncogenic fusion rearrangements, CIC-DUX4 and BCOR-CCNB3, in a significant subset of Ewing-like sarcomas. Uncovered alternate fusion partners broadened the proposed classification of these tumors to CIC-rearranged sarcomas and BCOR-rearranged sarcomas. This article summarizes the clinicopathologic and molecular features of these entities, with particular attention paid to those features that overlap with and distinguish these sarcomas from other round cell sarcomas.


Subject(s)
Sarcoma, Small Cell/pathology , Soft Tissue Neoplasms/pathology , Biomarkers, Tumor/genetics , Cell Differentiation/genetics , Diagnosis, Differential , Humans , Immunohistochemistry , Molecular Typing , Oncogene Proteins, Fusion/genetics , RNA-Binding Protein EWS/physiology , Sarcoma, Small Cell/classification , Sarcoma, Small Cell/genetics , Soft Tissue Neoplasms/classification , Soft Tissue Neoplasms/genetics
6.
Mol Cancer Res ; 17(3): 731-740, 2019 03.
Article in English | MEDLINE | ID: mdl-30610106

ABSTRACT

The molecular events driving low-grade endometrioid endometrial carcinoma (LGEC) development-like in many cancers-are incompletely understood. Hence, here we performed multiregion, comprehensive somatic molecular profiling of routinely processed formalin-fixed, paraffin-embedded (FFPE) material from 13 cases of LGEC totaling 64 minute, spatially defined cell populations ranging from presumed precursor lesions through invasive LGEC. Shared driving PTEN, PIK3R1, or PIK3CA mutations support clonal origin of the samples in each case, except for two cases with two clonally distinct neoplastic populations, consistent with unexpected multiclonality in LGEC development. Although substantial heterogeneity in driving somatic alterations was present across populations in nearly all cases, these alterations were usually clonal in a given population, supporting continued selection and clonal sweeping of driving alterations in populations with both precursor and LGEC histology. Importantly, CTNNB1 mutational status, which has been proposed as both prognostic and predictive in LGEC, was frequently heterogeneous and subclonal, occurring both exclusively in precursor or cancer populations in different cases. Whole-transcriptome profiling of coisolated RNA from 12 lesions (from 5 cases) was robust and confirmed histologic and molecular heterogeneity, including activated Wnt signaling in CTNNB1-mutant versus wild-type populations. Taken together, we demonstrate clinically relevant multiclonality and intratumoral heterogeneity during LGEC development with important implications for diagnosis, prognosis, and therapeutic prediction. More broadly, our methodology is broadly scalable to enable high-throughput genomic and transcriptomic characterization of precursor and invasive cancer populations from routine FFPE specimens. IMPLICATIONS: Multiregion profiling of LGEC populations using a highly scalable approach demonstrates clinically relevant multiclonality and intratumoral heterogeneity.


Subject(s)
Carcinoma, Endometrioid/genetics , Endometrial Neoplasms/genetics , Carcinoma, Endometrioid/pathology , Class I Phosphatidylinositol 3-Kinases/genetics , Class Ia Phosphatidylinositol 3-Kinase/genetics , Endometrial Neoplasms/pathology , Female , Humans , Mutation , Neoplasm Grading , PTEN Phosphohydrolase/genetics , Paraffin Embedding
7.
Arch Pathol Lab Med ; 142(10): 1196-1201, 2018 10.
Article in English | MEDLINE | ID: mdl-30281368

ABSTRACT

CONTEXT.­: Biphenotypic sinonasal sarcoma (BSNS) is a rare, slow-growing soft tissue sarcoma of the sinonasal tract, typically presenting with nonspecific obstructive nasal symptoms. Although recurrences are common, no metastases have been reported, and only 1 patient has died of disease thus far. It characteristically demonstrates rearrangements of PAX3 with multiple fusion partners, the most common of which is MAML3. OBJECTIVES.­: To highlight the most important diagnostic features, including morphologic, immunohistochemical, and molecular findings, and to provide comparisons to other entities in the differential diagnosis. We also aim to provide a summary of the clinical features and outcomes in cases reported to date. DATA SOURCES.­: Recently published literature encompassing BSNS and its synonym, low-grade sinonasal sarcoma with neural and myogenic differentiation. CONCLUSIONS.­: BSNS is a sinonasal tumor that is important to recognize because its biologic behavior differs from most of the entities in the differential diagnosis. The diagnosis can typically be rendered through a combination of morphology, immunohistochemical stains, and ancillary testing for characteristic PAX3 rearrangements.


Subject(s)
Paranasal Sinus Neoplasms/pathology , Sarcoma/pathology , Humans
8.
Arch Pathol Lab Med ; 142(10): 1182-1185, 2018 10.
Article in English | MEDLINE | ID: mdl-30281370

ABSTRACT

CONTEXT.­: Atypical ductal hyperplasia (ADH) is a challenging diagnosis defined by cytologic and architectural features that carries an increased risk of subsequent carcinoma when diagnosed in isolation. In addition, ADH may secondarily involve benign breast lesions, wherein it carries variable clinical significance. OBJECTIVES.­: To review the diagnostic criteria and clinical significance of ADH in isolation and as it involves benign breast lesions, and to review the evolving literature on its molecular signature. DATA SOURCES.­: Recently published studies that collectively examine ADH were reviewed. CONCLUSIONS.­: Atypical ductal hyperplasia carries an increased risk of subsequent carcinoma in isolation and when it involves most benign breast lesions. Identifying which cases of ADH will be upgraded to carcinoma has been challenging, and new laboratory developments, such as EZH2 overexpression, may have a future role.


Subject(s)
Breast Neoplasms/pathology , Carcinoma, Intraductal, Noninfiltrating/pathology , Breast Neoplasms/diagnosis , Breast Neoplasms/genetics , Carcinoma, Intraductal, Noninfiltrating/diagnosis , Carcinoma, Intraductal, Noninfiltrating/genetics , Female , Humans
9.
Am J Surg Pathol ; 41(6): 801-809, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28288038

ABSTRACT

Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is caused by germline mutations in the FH gene, and is associated with increased incidence of leiomyomas and a potentially aggressive variant of renal cell carcinoma (HLRCC-associated RCC). Absent immunohistochemical expression of fumarate hydratase (FH) has previously been used to diagnose HLRCC-associated RCC, but immunohistochemical staining of leiomyomas is not standard practice. We performed immunohistochemistry (IHC) on whole sections from consecutive cutaneous leiomyomas from our archives to evaluate for both FH and succinate dehydrogenase B expression, in addition to clinicopathologic data collection and review of all hematoxylin and eosin-stained slides for blinded morphologic evaluation of features reported to be seen in HLRCC-associated uterine leiomyomas. Ninety-six cutaneous leiomyomas from 87 patients were identified; 12 of these specimens were from 7 patients with documented HLRCC. FH expression by IHC was absent in 9 specimens and retained in 85 specimens; 2 cases were equivocal with minimal FH expression. Seven of the 9 absent expression specimens were from patients with HLRCC, as were both of the equivocal specimens. The overall sensitivity and specificity of absent FH expression in leiomyomas for detection of patients with HLRCC were 70.0% and 97.6%, respectively. Inclusion of cases classified as equivocal increased sensitivity to 75.0%. Succinate dehydrogenase B expression was retained in 95 specimens and equivocal in 1 specimen. None of the evaluated morphologic features showed any association with leiomyomas in HLRCC. Loss of FH immunohistochemical expression in cutaneous leiomyomas is a sensitive and specific marker for detection of HLRCC, thus suggesting a role for prospective FH IHC in patients with these tumors to screen for HLRCC.


Subject(s)
Biomarkers, Tumor/metabolism , Fumarate Hydratase/metabolism , Leiomyomatosis/diagnosis , Neoplastic Syndromes, Hereditary/diagnosis , Skin Neoplasms/diagnosis , Succinate Dehydrogenase/metabolism , Uterine Neoplasms/diagnosis , Adolescent , Adult , Databases, Factual , Female , Humans , Immunohistochemistry , Leiomyomatosis/enzymology , Leiomyomatosis/pathology , Male , Neoplastic Syndromes, Hereditary/enzymology , Neoplastic Syndromes, Hereditary/pathology , Sensitivity and Specificity , Single-Blind Method , Skin Neoplasms/enzymology , Skin Neoplasms/pathology , Uterine Neoplasms/enzymology , Uterine Neoplasms/pathology
10.
J Plast Reconstr Aesthet Surg ; 64(2): 148-54, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20547117

ABSTRACT

BACKGROUND: Studies of facial aging up to the present have largely been observational and subjective. This study applies state-of-the-art facial imaging and three-dimensional computer modelling to measure changes in the aging female face. The markers of facial aging discussed here go beyond descriptive accounts by individual practitioners and are presented as quantitative measurements of the volume change in the aging periorbital region. METHODS: Three-dimensional image data sets were acquired of 42 mother-daughter matched pairs (83 individuals). Overall similarity of the faces of the mother-daughter pair were confirmed using best fit analyses prior to further processing of the data. The changes in facial structure secondary to aging were measured using volumetric comparisons of periorbital tissues in the daughter and mother. The age range of the individuals imaged range from 15 to 91 years. RESULTS: A consistent pattern of volume difference and regression of soft tissues associated with the medial canthus nasojugal groove was demonstrated in the aged individual of each pair. The volume difference associated with the tear trough ranged from 0.02cc to 1.27cc with median values of 0.38cc and 0.42cc. Volume differences in the adjacent periorbital tissues are also measured. CONCLUSIONS: Imaging clearly shows a consistent pattern of atrophy and regression of soft tissues associated with the medial canthus and nasojugal groove. Histogram depth analysis of the soft tissue shows greatest atrophy in the medial canthal region and soft tissues caudal to the lower lid. Volumetric analysis of the atrophy of these tissues is a useful adjunct in the accurate rejuvenation of the periorbital region.


Subject(s)
Aging , Imaging, Three-Dimensional , Adolescent , Adult , Aged , Aged, 80 and over , Aging/physiology , Atrophy , Eye , Face , Female , Humans , Middle Aged , Models, Theoretical , Young Adult
11.
Allergy Rhinol (Providence) ; 2(1): 40-2, 2011 Jan.
Article in English | MEDLINE | ID: mdl-22852114

ABSTRACT

A 74-year-old immunocompetent man admitted for severe retro-orbital headache was diagnosed with isolated sphenoiditis. At the time of scheduled surgery, the patient was mildly obtunded, and a head CT revealed a temporal lobe abscess. The patient underwent a left temporal craniectomy and a bilateral endoscopic sphenoid sinusotomy, which revealed gross fungal debris. The patient made a full recovery with resolution of abscess and sinus findings. Suspicion for intracranial infection should be raised in any sinus patient with neurological changes. Early diagnosis with imaging studies is extremely important for surgical drainage before permanent neurological sequelae.

SELECTION OF CITATIONS
SEARCH DETAIL
...